Immunoassay News and Research

RSS

Detecting Auto-Antibodies for Early Identification of High-Risk COVID-19 Cases

Researchers recently discovered that auto-antibodies against their type 1 interferons, crucial immunological signaling proteins, were present in some COVID-19 patients.

20 Jun 2024

CRISPR/Cas Biosensors Address Sensitivity and Specificity Challenges in Detection

The mechanisms of CRISPR-Cas-based biosensors.

5 Jun 2024

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification.

28 Aug 2023

AI-Aided Sensor Offers Hope for Early Detection of Neurodegenerative Diseases

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases (NDDs) such as Parkinson's disease (PD) and Alzheimer's disease (AD).

13 Jul 2023

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

...

From The Native Antigen Company 8 Dec 2022

Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents

Gyros Protein Technologies AB today introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits.

From Gyros Protein Technologies AB 30 Nov 2022

The Native Antigen Company introduces new range of influenza antigens

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.

From The Native Antigen Company 21 Nov 2022

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Combining Alamar's Attobody™ platform with Mologic's RDTs, this collaboration focuses on developing highly sensitive COVID-19 tests for global health readiness.

5 May 2022

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company today announced the expansion of its norovirus-like particle range, with the addition of six new reagents.

From The Native Antigen Company 13 Jan 2022

Carolina Liquid Chemistries Corp. Introduces Line of Water Systems for Clinical Chemistry Analyzers

Carolina Liquid Chemistries Corp. has introduced a new line of laboratory water systems to the USA market.

From Carolina Liquid Chemistries Corp. 6 Oct 2021

Study finds a correlation between zika-induced neurological complications and Gas6 protein

An article by Brazilian researchers published in the journal Brain, Behavior, and Immunity elucidates one of the mechanisms whereby zika virus causes neurological complications in adult patients and microcephaly in fetuses. The discovery paves the way for future research to develop drugs that combat the virus.

4 Oct 2021

Rapid, more accurate test to detect antibodies against SARS-CoV-2 spike protein

Japanese researchers have come up with a highly accurate, rapid test for identifying antibodies against the SARS-CoV-2 spike protein in human serum.

19 Jul 2021

Novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on HC-FIA

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care.

11 Dec 2020

Serologic testing of COVID-19 patients as an adjunct diagnostic method

A recent paper explored the possibility of using serologic testing as an adjunct diagnostic method in the diagnosis of SARS-CoV-2 infection.

28 Oct 2020

Krystal binding microplates set a new standard for uniform, reproducible capture of biomolecules

Porvair Sciences new medium and high bind Krystal microplates set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as ELISA's.

From Porvair Sciences Limited 16 Oct 2020

Researchers develop novel technology to detect cancer biomarkers

A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers. The research is published in Nature Communication Biology.

16 Jul 2020

New rapid, sensitive test can detect COVID-19 cases

With the number of COVID-19 cases reducing in the United States and elsewhere, public health officials are attempting to understand the proportion of people who have been infected by coronavirus.

30 Apr 2020